Introduction
Cytochrome P450 BM3, also referred to as CYP102A1, is a soluble, fatty acid hydroxylase from Bacillus megaterium, and is a very promising biocatalyst due to its high catalytic activity and stability. 1 In the last few decades, CYP450 BM3 has been intensively studied both structurally and mechanistically. 2 Because its natural substrates are long chain fatty acids, wild type (WT) BM3 is not able to efficiently metabolize (hydrophilic) drug-like compounds. 3 However, it has been shown that WT BM3 can be adapted for biocatalytic purposes and the enzyme has been subject to many mutation studies, which have led to the identification of a variety of mutants showing biocatalytical activity towards non-natural substrates. 4 Many of the previously designed and identified biocatalytically active mutants are potent candidates for use in biotechnology, because they convert a variety of substrates into therapeutically or diagnostically useful products and they display a broad range of substrate specificity and regio-and stereoselectivity. 4d,e,5 By employing genetic engineering techniques, they can additionally be modified using random or site-directed mutagenesis to further improve their activity, stability and regio-and stereoselectivity. 6 In order to rationalize results of such mutagenesis studies or to even guide them, in silico modelling has proven to be a useful and synergetic tool to predict and structurally rationalize the effect of (critical) mutations. 7 For example, previous combined experimental and computational efforts in our laboratory 4d have led to the design and elucidation of new drug metabolising mutants of BM3 7b, 8 that can convert a variety of drug-like compounds such as MDMA and dextromethorphan. One of them is mutant M01, for which mutations with respect to WT BM3 are depicted in Figure 2 .1, and concern WT residues R47, L188, F87, E267 and G415. R47 and L188 are located in the hydrophobic entrance channel of the enzyme, close to the protein surface. R47 is known to be involved in recognition of BM3's natural substrates by interaction with the carboxylic group of the fatty acids. 3 E267 and F87 are closer to the catalytic heme center, and the latter is known to play a crucial role in substrate selectivity. 9 F87 is positioned above the heme porphyrin plane, preventing the binding of large substrates near the catalytic iron center in WT BM3. Mutation of F87 into a smaller residue appears to be of critical importance in making BM3 susceptible to non-natural substrates. 10 Another residue that may be of general interest as a target for sitedirected mutagenesis is A82. Huang et al. 11 recently showed that replacement of A82 in WT BM3 (Figure 2 .1) by a bulky side chain leads to a significant increase in catalytic activity for its fatty acid substrate palmitate, which can bind more tightly than to wild type.
Here we report an in silico rationalization study of experimentally determined trends for M01 and its mutant M01 A82W in metabolism of the steroid testosterone (TES). WT CYP540 BM3 is known to show no activity towards the TES substrate. 12 In contrast and like human CYP450s, 13 drug-metabolising BM3 mutants such as M01 typically metabolize TES by oxidative insertion into its aliphatic C-H groups. 2b,14 Because TES has 21 regio-and/or stereo-chemically different aliphatic hydrogens, it is an ideal candidate to screen (libraries of) mutants for the effect of amino-acid mutations on substrate selectivity and on patterns in metabolite formation by means of regio-(or stereo-) selectivity. 15 In addition, there is great industrially interest in biocatalysts that selectively hydroxylate TES (and other steroids) at its B-or C-ring, whereas to our knowledge available BM3 mutants typically hydroxylate TES at its C2, C15 or C16 positions in the A-and D-ring 12, 16 (see Figure 2 .2 for the employed TES atom numbering). Interestingly, Rea et al. 16 recently reported that introduction of mutation A82W into mutant M01 significantly affects regioselectivity (i.e., in the position of hydroxylation) of TES metabolism. CYP450 BM3 mutant M01 was found to catalyze the formation of three hydroxylation products of TES, namely 2β-OH, 15β-OH and 16β-OH TES, corresponding to oxidative insertion into the C-H bond at the C2, C15 or C16 position, respectively, leading to β-stereoproducts in all three cases. In contrast, mutant M01 A82W was found to almost exclusively catalyze the formation of the 16β-OH metabolite, 16 see Table 2 .1. hydroxylation of TES by CYP450 BM3 mutants M01 and M01 A82W. The total number of docked poses of TES in the active site of CYP450 BM3 mutants M01 and M01 A82W, for which C2, C15 or C16 was determined to be the carbon atom in closest proximity to the heme iron atom and within a range of 0.3-0.7 nm from the heme iron, are shown in parentheses.
The current study reports efforts on constructing an in silico model for the prediction of regioselectivity in TES hydroxylation by BM3 mutants, with the purpose of structurally rationalizing the experimental trends described in reference 16 , and ultimately, designing mutants that open up possibilities to form new biocatalytic metabolites. For biotechnological purposes, methods capable of understanding and predicting the substrate's preferred site-of-metabolism (SOM) can significantly contribute to efficiency when designing more active and (regio)selective mutants or when screening large databases of mutants or compounds for specific metabolite formation. Computational methods for SOM prediction in CYP450s are usually protein-structure (docking) based with the aim of determining possible substrate orientations with respect to the catalytically active heme iron. 17 In addition, QM estimates of the (intrinsic) reactivity of potential metabolic sites of the substrate can be taken into account to further guide SOM prediction. 18 In the current work, we report the intrinsic (gasphase) reactivity of TES C-H bonds, and our attempts to structurally rationalize the experimentally observed changes in TES metabolism (when comparing M01 and M01 A82W) using a protein structure-based in silico approach. This is a challenging task, because BM3, as well as many other CYP450s, displays large active site plasticity and flexibility, which can have large effects on the outcomes of docking-based procedures 19 Note that CYP plasticity provides a possible explanation for CYP450s being able to bind such a broad and diverse range of substrates, and makes it a challenging target for SOM prediction. 20 In recent years, docking approaches have been extended with new implemented tools in order to take flexibility into account. 7e,21 Here, we report on the application of a previously reported combined approach, 19 in which MD simulations and ligand docking are combined in order to reproduce the shift in regio-selectivity of TES metabolism when introducing the A82W mutation into M01. While docking can be considered to be a high-throughput virtual screening procedure, suitable to reach industry efficiency rates, molecular dynamics (MD) simulations give more in-depth insights into the dynamic behavior of proteins, providing microscopic detail, although on a low-throughput scale. Using our model, large effects of protein active site plasticity and flexibility on the results of our docking predictions were observed: it was found that changes in the conformation of single amino acids may lead to large differences in the outcomes of site-of-metabolism prediction. However, our model was shown to fail in quantitatively predicting the experimentally observed ratios in metabolite formation by mutants M01 and M01 A82W. Despite of this, useful structural insights could be derived from the observed docking poses in terms of substrate interactions with active-site residues, which probably drive TES binding orientation and therefore form the basis for the experimentally determined shift in regioselectivity by introducing bulky tryptophan at position 82 in mutant M01 A82W.
Methods

QM Calculations
To assess the intrinsic reactivity of the individual carbon atoms, QM calculations were performed to estimate the energy cost ΔE associated to the conversion of the TES substrate (RH)
into radicals R· and H·, by breaking one of its C-H bonds:
(Eq. 2.1)
Energies of RH (ERH), R· (ER·) and H· (EH·) were calculated using the ADF program 22 at the BP86 level of theory, using the TZ2P basis set. At this level of theory, computed C-H bond activation energies were previously shown to be accurate within the order of 5 kJ/mol. 23 The radicals R· and H·were treated using the spin-unrestricted formalism as implemented in ADF. 24 ΔE is then determined as: 25 Note that, like in previous modeling studies of M01, 7b mutation G415S was not taken into account in our in silico work because it was shown not to contribute to the enhanced activity of the mutant. The starting structure for MD simulations of mutant M01 A82W was modeled based on the M01 coordinates, using the molecular modeling software MOE (Molecular Operating Environment). 26 The side chain of 82W was manually introduced using MOE's builder tool such that it had minimal overlap with surrounding residue atoms. After introduction of the mutation A82W, polar and aromatic hydrogen atoms were added and the mutant's structure was energy minimized in vacuo. Starting coordinates for the complexes of TES with M01 A82W were selected from the docking study described below, and energy minimized in vacuo as well. All energy minimizations were carried out using the GROMOS05 biomolecular simulation package 27 and the GROMOS force field parameter set 45A4. 28 Subsequently, the proteins and mutant-substrate complexes were solvated in periodic rectangular boxes, containing ~18,000 SPC water molecules, 29 using a minimum solute to wall distance of 0.8 nm, and 15 Na + ions to neutralize the system. The starting configuration for the solvated M01 and M01 A82W systems comprised 18,055 and 18,008 water molecules, respectively, with periodic box volumes of 8.6 x 8.6 x 8.6 nm. The force-field parameters that were used to describe the CYP450 BM3 protein and sodium ions were taken from the GROMOS parameter set 45A4. 28 In a first set of (equilibration) MD simulations, the system was gradually heated up to 298 K, in seven separate simulation steps of 20 ps each (at 50, 100, 150, 200, 250 and 298 K, respectively), in which the volume of the system was kept constant. In the first five simulations, position restraints were applied on the protein atoms (and on the TES atoms in the simulations of the protein-TES complexes) using a gradually decreasing force constant (of 25000, 2500, 250, 25 and 2.5 kJ mol -1 nm -2 , respectively) for the harmonic restraints. After the equilibration process, a production MD simulation at 298 K with a total length of 5 ns of the systems followed. In the production MD simulations, no position restraints were applied, and the pressure was kept constant to a target value of 1 atm, using a Berendsen barostat with a coupling time of 0.5 ps. The isothermal compressibility was set to 4.575 x 10 -4 (kJ mol -1 nm -3 ) -1 . In all simulations, a time step of 2 fs was used, and the temperature was kept constant at its target value by using a Berendsen thermostat with a coupling time of 0.1 ps. Bonds were kept constrained using the SHAKE algorithm, 30 with a geometric tolerance of 10 -4 . At every time step, nonbonded interactions were calculated up to a distance of 0.8 nm, by means of a pair list, generated every five time steps. At every fifth time step, intermediate-range interactions at distances up to 1.4 nm were calculated and kept constant. A reaction-field contribution was added to the energies and forces, to account for the electrostatic interactions outside the cut-off radius of 1.4 nm, with a dielectric permittivity of 61. During the production runs, energies were stored every 250 steps (0.5 ps) for analysis. After the 5 ns MD run of the proteins, 2500 coordinate frames were generated by writing out protein coordinate files every 1000 steps (2 ps), which were used as template structures in further docking studies (after adding aliphatic hydrogens using the corresponding tool in MOE). Molecular structures of the substrate TES for use in docking were manually built using the MOE program and energy minimized using the MMFF94x force field as implemented in MOE. Two distinct molecular conformations can be distinguished for TES: a 'flat' conformation and a 'bent' conformation, characterized by a trans-or gauche-orientation of the dihedral angle defined by atoms C2, C1, C10 and C9, respectively. 31 In both conformations, the B-and C-ring are in a chair conformation. For every docking run, eight different sets of atomic coordinates of TES were used as input structure, to improve sampling of the ligand within the binding cavity during the docking runs. For this purpose, four different absolute orientations within Cartesian space were used for both the flat and bend conformation of TES. These four orientations were generated by manually rotating TES along its cross-section axis and/or the axis perpendicular to the B-and C-ring of TES, using the PyMol software. 32 Combining the 2 x 4 different TES orientations and the 2,500 protein structures obtained from the MD simulations of M01 and M01 A82W (see Figure 2. 3), TES was docked into the protein active-sites using the GOLD (Genetic Optimization for Ligand Docking) 33 software, version 4.0, and the ChemScore scoring function 34 optimized for heme groups. 35 The center point for docking was defined by the mirror image of the sulfur atom of Cys400 on the opposite site of the heme iron, from which the radius was set to 1.5 nm to define the active-site of the protein.
A maximum of 50,000 operations in the GOLD genetic algorithm were performed, using a population of 100 genes. After every docking simulation, (maximally) 50 of the highest-ranked obtained poses were retained for further analysis. In total, circa 200,000 protein-TES complexes were thus obtained per mutant and were used as input for post-processing analysis. The flow chart of the combined MD/docking procedure is shown in Figure 2 .3. 
Analysis
For efficiency and accuracy purposes, an automated analysis tool was generated, in order to assess the obtained docked poses. Obtained binding poses were counted in which ring methylene carbon atoms and C4 were closest to the catalytic heme iron, after discarding the poses for which the evaluated carbon atom was positioned more than 0.7 nm away from the heme iron center (which is slightly larger than the hypothetical cut-off of 0.6 nm for catalytic activity 18c ) or closer than 0.3 nm to the heme iron (considering that accommodation of a reactive oxygen molecule should be possible). Subsequently, the same statistical analysis was performed for different time spans within the simulation, as well as for groups of protein configurations obtained from the MD simulations and structurally clustered based on similarity in the positional root-mean-square deviations of the active-site atoms (after fitting the protein structures based on all backbone atoms; the active site was defined by atoms of Ser72, Ala74, Leu75, Ala/Trp82, Phe/Val87, Ala264, Thr268, Ala328, Pro329, Ala330, Ser332, Met354, Leu437, Thr438, and the heme moiety). Finally, poses for which carbon C2, C6, C12, C15 or C16 was closest to the catalytic heme iron were considered for further analysis. These poses were clustered based on similarity in calculated root-mean-square deviations of atomic positions, 36 so that structurally similar binding orientations were grouped together. Members of the obtained clusters of binding poses were analyzed in terms of key interactions with the protein active site.
Results & Discussion
QM estimates of the intrinsic reactivity of TES' C-H bonds
In Table 2 .2, the intrinsic reactivities of selected individual carbon-hydrogen bonds of TES are expressed in terms of the energy cost ΔE associated with reaction (2.1). Table 2 .2 shows a C-H bond in the B-ring (at position C6) to have the lowest value for ΔE (356.5 kJ/mol) and, consequently, the highest intrinsic reactivity. This is probably due to the stabilizing effect of the double bonds in the A-ring on formation of the C6 R· radical in reaction (2.1). However, to our knowledge, current CYP450 BM3 mutants typically hydroxylate TES at its C2, C15 or C16 positions in the A-and D-ring, and not at positions in the B-and C-ring, 12, 16 which must be explained in terms of substrate binding orientation towards the catalytic heme iron instead. It is also interesting to observe that the C-H bond at position C2 (ΔE = 398.3 kJ/mol) has a higher intrinsic reactivity than C16 (ΔE = 420.9 kJ/mol), due to the stabilizing effect of the adjacent C=O bond on formation of the C2 R· radical, and that the intrinsic reactivity of C-H bonds at the C15 and C16 position only differ by 5.4 kJ mol -1 , see Since mutant M01 A82W is known to selectively hydroxylate TES at C16 (Table 2 .1), also this observed trend in intrinsic reactivity of TES' C-H bonds indicates that substrate orientation with respect to the heme catalytic center in the active site of the biocatalyst, which is studied in detail in the combined MD/docking study as described in this work, is a determining factor for the observed regioselectivity of TES hydroxylation by the BM3 mutants. This is in line with several previous computational (or combined experimental/computational) studies which reported that reactivity alone cannot explain observed trends in regioselective hydroxylation of substrates by e.g. WT BM3 37 or CYP450 2J2. 38
BM3 plasticity: effect on metabolite prediction in docking studies
It is well known that CYP450s show a large active-site plasticity. [19] [20] In order to assess the effect of BM3 plasticity on metabolite prediction (in terms of TES binding orientation with respect to the catalytically active heme iron), preliminary docking studies were performed in which TES was docked into a set of seven protein conformations of M01 based on the modeled structure of Stjernschantz et al. 7b These seven structures only differ in terms of the side-chain orientation of active-site residue Leu437, and were obtained by performing amino-acid side chain rotations along the two bonds connecting the Cα and Cβ, and the Cβ and Cγ atoms of Leu437. Percentages were calculated for the poses in which C2, C15 or C16 are in closest vicinity of the heme iron atom, corresponding to preferred hydroxylation at these positions. Interestingly, it was found that depending on the orientation of Leu437, the prediction of the site of metabolism (SOM) may completely reverse. For example, in one of the rotameric structures 100% of the docked poses were oriented such that C2 is closest to the heme iron, whereas for another rotamer, 100% of the docked poses were oriented such that C16 is closest to Fe. We note that both of these rotamers were observed during the MD simulations of M01. This indicates that protein flexibility should be taken into account in SOM prediction, which was done in the remaining by performing MD simulations to generate a large ensemble of protein structures to dock the TES substrate into. 19,21d 
MD simulations of M01 and M01 A82W
To test the stability of the protein structures during the MD simulations, the root-mean-square deviations (RMSD) of the backbone heavy atoms from the initial structure were calculated throughout the simulations. Mutant M01 shows RMSD convergence within 5 ns to a value of 
Prediction of regioselectivity
Subsequently, TES was docked into the active site of M01 and M01 A82W by using the protein structures as obtained from the MD simulations (Figure 2. 3). Both a 'bent' and a 'flat' conformation of TES (as defined in Section 2.2.) were used for docking because our results showed that for most of the predicted sites-of-metabolism, significant percentages of both TES conformations were found within the sets of binding poses in which the corresponding (ring) carbon atoms were predicted to be in closest vicinity to and within a catalytic range of the heme iron (Appendix 2.A). Docking results are summarised in Table 2 .1 and Figure 2 .6. For the TES methylene carbon atoms and C4, Figure 2 .6 presents percentages of TES binding poses as docked into M01 and M01 A82W, in which the corresponding carbon atom is closest to and within 0.3-0.7 nm of the heme iron. These percentages show a mismatch between the predicted metabolism profile and experiment: experimentally, only C2, C15 and C16 metabolites are observed, whereas our docking runs also predict significant amounts of binding poses that correspond to hydroxylation at other positions, especially at C6 and C12 (hydroxylation at C4 was not considered further because of the large value for ΔE associated with C-H bond breaking when compared to other values presented in Table 2 .2, which is due to the double-bond character of the C4-C5 bond). Note that this mismatch is also found when using different subsets of protein conformations for docking as collected from various time periods in simulation ( When considering the calculated ratio between the experimentally determined SOMs C2, C15 and C16 only, discrepancies are also found between the computationally predicted and experimentally observed regioselectivity in position of hydroxylation. In the M01 docking poses, C16 is predominantly found to be closest to the catalytic heme iron (whereas a preference for C2 and C15 hydroxylation is observed experimentally), and in M01 A82W, a similarly large number of docking poses are obtained in which C2 or C16 are predicted to be closest to the heme iron (whereas in experiment, C16 metabolites are almost exclusively found). These observations have been summarised in Table 2 .1, which shows percentages (as well as total numbers) of docked poses in which carbons C2, C15 or C16 are positioned closest to the heme iron and within a catalytically active distance to Fe. Also this discrepancy between experiment and simulation was found not to be affected when only docking into subsets of protein conformations taken from different periods of simulation (Figure 2.6 19 However, the application of a similar procedure in this work to quantitatively reproduce experimental data on the detailed metabolism profile of only a single compound (TES) by CYP450 BM3 mutants, clearly remains a challenging task. To investigate the effect of protein flexibility and active-site plasticity on the outcomes of our SOM predictions more extensively, the results of docking TES into protein structures obtained from different time frames during simulation (Figure 2 .6) have been studied in more detail. Thereby we focused on predicted ratios in C2, C15 and C16 hydroxylation. Although large variations in this ratio were observed when considering single protein conformations separated by only a few picoseconds in simulation time (which is in line with findings reported in, e.g., the combined MD/docking SOM-prediction study of CYP450 2D6 substrates by Hritz et al.) , 19 qualitatively similar trends were observed when comparing calculated ratios for the time frames as presented in Figure 2 .6. For M01 A82W, the predicted ratio of metabolite formation changes from an almost equal distribution for C2, C15 or C16 hydroxylation when considering docking results for the protein conformations obtained from the 750-1500 ps time frame of the MD simulation, to a relatively larger ratio of C16 metabolite prediction and a significant decrease in C15 metabolite prediction, based on the docking poses obtained for the conformations of the 1500-3000 ps time frame (Figure 2.6B) . Interestingly, these changes in profile in SOM prediction correlate with the change in conformation of the side chain of Trp82 (Figure 2.4) . The corresponding change in side-chain orientation apparently influences the shape of the active site such that parallel orientation of the Trp82 indole group with respect to the heme group (see Figure 2 .5D) results in a less favorable active-site shape to host C15 hydroxylation. This hints on guidance by the Trp82 side-chain orientation on the preferred binding orientation of the substrate. Similar findings were recently observed for residue Phe483 of CYP450 2D6 in the combined MD/docking study of Hritz et al., 19 which showed an important role for Phe483 side-chain orientation on SOM predictions. Based on the comparison of our docking results with experiment, it is impossible to evaluate which orientation(s) of Trp82 in the active site should be included to achieve a more accurate prediction of regioselectivity in TES hydroxylation. However, after clustering the M01 A82W structures based on RMSD values of the active-site atomic positions, an interesting additional analysis of our docking results could be performed. A preference for C16 hydroxylation is correctly predicted when docking TES in the central member of the largest of the obtained clusters, see Figure 2 .7D. In this M01 A82W structure, Trp82 has adopted a conformation characterized by Cα − Cβ and Cβ − Cγ dihedral angles of 290° and 280°, respectively, but care
should be taken in considering this conformation as being most relevant, because for both the cluster of structures (Figure 2 .7B) and the MD time frame (1500-3000 ps, Figure 2 .6B) this particular structure belongs to, docking statistics do not correctly predict the experimentally observed hydroxylation profile (Table 2. . This is again a manifestation of the active-site plasticity that has to be taken into account in the docking studies, because all three Trp82 conformations may contribute to protein-ligand interactions.
Structural rationalization
As discussed above, predicted trends in regioselectivity in TES hydroxylation by M01 and M01 A82W (Figure 2.6 and Table 2 .1) are deviating from experiment (Table 2 .1). First of all, M01 and M01 A82W are known to only generate C2, C15 and C16 metabolites, whereas our docking runs also predict a significant number of TES binding poses corresponding to hydroxylation at other positions, especially at C6 and C12 (Figure 2 .6). A detailed structural analysis of obtained binding poses in which C6 or C12 is closest to the heme iron revealed that the prediction of sitesof-metabolism other than those observed in experiment is probably due to incorrectly scoring the steric clashes (in terms of overlap between heavy atoms that are within 0.15-0.25 nm of each other) that were systematically observed between TES carbon atoms and side-chain and backbone atoms of Leu437 and Pro329 (C6 orientation in M01) and/or of I'-helix residues Ala264, Val267 and Thr268, see Figures 2.8A and 2.8B. Furthermore, an increase in 16-OH hydroxylation was observed by Rea et al. 16 upon introducing the A82W mutation, whereas in contrast, our in silico approach predicts the opposite, see Table 2 .1. This limitation of the combined MD/docking approach in quantitatively predicting trends in regioselectivity may be due to restrictions in accounting for kinetic effects in the binding or proton-abstraction process, 37 but is probably also caused by problems in correctly ranking the binding poses in which C2, C15 or C16 are in closest vicinity of the heme iron. As discussed below, a detailed structural analysis of M01 and M01 A82W binding poses in which C2, C15 or C16 is closest to the heme iron indicates that the incorrect prediction of the ratio of C2, C15 and C16 hydroxylation is probably due to limitations in correctly scoring the possible hydrogen-bonding interactions of TES in these binding orientations with active-site residues. After assembling the generated docking poses in which C2, C15 or C16 are closest to the heme iron, and grouping them according to the carbon atom that is in closest vicinity of the heme iron center, the obtained groups of binding poses were subjected to a clustering analysis based on similarity in ligand-atom positional RMSD values. Central members of the largest clusters of TES binding poses in the M01 and M01 A82W active site, for which C2, C15 and C16 were found to be closest to the heme iron atom, are schematically depicted in Figure 2 .5, panels A-F. Interestingly, in the M01 active site two groups of clusters can be distinguished for binding poses corresponding to both C2 (Figure 2 .5A), C15 (Figure 2 .5C) and C16 hydroxylation (Figure 2 .5E).
One of these groups of binding poses typically occupies the cavity that is (partly) filled by Trp82 in the M01 A82W active site, and this group of clusters disappears upon introduction of the A82W mutation (see Figures 2 .5B, 2.5D and 2.5F). Closer inspection of the remaining binding modes of members of the C16 clusters (Figure 2 .5F) reveals the abundant presence of hydrogen bonding interactions between the TES' hydroxyl group and the C=O backbone moiety of Ala264 and, to a lesser extent, of Thr260. Because TES does not carry a hydrogen bond donating group on its A-ring, hydrogen bonding to Ala264 and Thr260 is not observed for binding orientations which favor C2 metabolism (Figure 2 .5B). In the binding orientation in M01 A82W corresponding to C15 hydroxylation (Figure 2.5D ), hydrogen bonding with Ala264 and Thr260 is less favorable due to the change in TES binding pose necessary for C15 orientation towards the heme iron. Together with the experimental finding that C2 and C15 hydroxylation by mutant M01 A82W is hardly observed and the too low predicted percentage of C16 metabolism (Table 2 .1), these findings hint on an overestimation of the possibilities of TES to bind in the orientations as depicted in Figures 2.5B and 2.5D. Opposite to the experimental findings for M01 A82W, M01 shows larger activity of TES for C15 and C2 hydroxylation than for C16 metabolite formation (Table 2 .1). Therefore, differences in preferred interactions for the TES binding pose situated within the A82 pocket (as depicted in Figure 2 .8, panels C, E and G), which were not found for M01 A82W, are probably responsible for preferred TES binding in an orientation corresponding to C15 (or C2) hydroxylation. Hydrogen-bonding interactions between TES and Threonines 88, 260 and 268 are observed in all three binding poses (see Figure 2 .8), and may be incorrectly evaluated in our docking procedure, considering the incorrect prediction of preferred C16 hydroxylation for M01 by our combined MD/docking procedure.
In conclusion, the structural analysis of representative TES binding orientations (Figures 2.5 and 2.8) offers an explanation for the structural basis of not only the experimentally observed trends in C2, C15 and C16 regioselectivity of TES hydroxylation, but also the mismatch of the computationally predicted ratios in metabolite formation with experiment as reported in this work. The substrate orientation responsible for C2 and C15 hydroxylation by M01 is the binding mode in which TES is occupying the part of the binding cavity close to Ala82 (Figures 2.8C and 2.8E). In M01 A82W, this binding orientation is sterically hindered by introducing bulky Trp82, and therefore not found back in the docking results for M01 A82W. Hydrogen-bonding interactions of TES with Ala264 and Thr260, which stabilize the substrate's binding orientation in the active site, offer an explanation for the preferred binding orientation in the M01 A82W active site corresponding to C16 hydroxylation, whereas interactions with Threonines 88, 260 and 268 may be responsible for preferred binding orientations in M01 suited for C2 and C15 hydroxylation. These findings may provide guidance for further mutation studies in the context of adapting selectivity in TES metabolism by BM3 mutants. Limitations of the combined MD/docking approach in correctly scoring and docking the hydrogen-bonding interactions of TES with these active-site residues, as well as the steric hindrance with residues P329, L437 and I'-helix amino acids in binding poses corresponding to B-or C-ring hydroxylation, are probably responsible for the discrepancy between computationally predicted and experimentally observed trends in regioselectivity in TES hydroxylation.
Conclusion
The current work presents a computational rationalization study on recently reported differences in regioselectivity of TES metabolism by CYP450 BM3 mutants M01 and M01 A82W. QM estimates of the intrinsic reactivity of TES' aliphatic C-H bonds could not explain the experimentally observed trends in regioselectivity of TES metabolism. Initial docking of TES into the active site of the mutants (in order to predict the binding orientation with respect to the catalytically active heme iron and hence, the site-of-metabolism (SOM) of TES) stressed the importance of taking protein flexibility and plasticity into account. Therefore, a combined MD/docking approach was employed for the protein-structure based prediction of regioselectivity in testosterone hydroxylation by the BM3 mutants, which indicated a correlation between the orientation of the bulky Trp82 side chain in the M01 A82W active site and the outcomes of the SOM predictions. Quantitatively, the experimentally observed trends in TES hydroxylation could not be reproduced using the employed combined MD/docking approach. First of all, TES hydroxylation at positions other than C2, C15 and C16 were incorrectly predicted. Moreover, also when only considering the obtained docking poses in which any of the observed sites-of-metabolism (C2, C15, C16) were in closest vicinity to the catalytic heme iron, discrepancies with experimental trends were observed: for M01, C16 was predominantly found to be closest to the iron centre (whereas a preference for C2 and C15 hydroxylation is observed experimentally), and in M01 A82W, a similarly large number of docking poses are obtained in which C2 or C16 are predicted to be closest to the heme group (whereas in experiment, C16 metabolites are almost exclusively found). A detailed structural analysis of the circa 200,000 obtained TES docking poses revealed that the discrepancy between experiment and computation is due to incorrectly scoring and ranking differences in specific TES-protein interactions that were observed for the possible TES binding modes (involving hydrogen bonding interactions with Ala264 and Threonines 88, 260 and 268 as well as steric contacts with Pro329, Leu437 and I'-helix residues). These differences can explain the experimentally observed trends in hydroxylation regioselectivity by M01 and M01 A82W.
